AzTrials
AzTrials

Knee OsteoarthritisNCT04769544

Comparison Between Medial Pivot Versus Symmetric Insert Total Knee Arthroplasty

A study testing total knee arthroplasty with medial pivot tibial insert or symmetrical insert in people with Knee Osteoarthritis, run by Elda University Hospital at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The functional outcome and longevity of total knee arthroplasty (TKA) is still a concern. Despite various developments in TKA designs, including fixed or mobile bearing, cruciate retaining or posterior stabilized, multi or single radius, it remains unclear which design is superior for achieving a physiological… Read more about this study

Who is it for?
Ages 50 to 99 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
total knee arthroplasty with medial pivot tibial insert or symmetrical insert
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteSpain
Study dates
1 Jan 2022to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary osteoarthritis of the knee
  • 50 years and older
  • Participants must be able to give informed consent

Who cannot join

  • Inflammatory arthritis
  • Traumatic etiology
  • Neurologic disease
  • Neoplastic disease
  • Morbid obesity
  • Severe collateral ligament instability (> 10° varus/valgus)
Show all 10Show fewer
  • Severe knee misalignment (greater than 10° of varus or valgus)
  • Flexion contracture greater than 15º
  • Prior surgery on the affected knee (except meniscus)
  • Knee arthroplasty in the contralateral knee

Trial locations and contacts

1 site in 1 country.

Alejandro Lizaur-Utrilla, MD, PhD contact

+34 966989019

lizaur1@telefonica.net

Spain1 site, 1 recruiting
  • Elda University Hospital

    Elda, Alicante, 03600

    Alejandro Lizaur-Utrilla, PhD, MD, lizaur1@telefonica.net

    Alejandro Lizaur-Utrilla, PhD, MD

    Recruiting

Other trials in Spain

About this study

Official title: Comparison Between Medial Pivot Versus Symmetric Insert Total Knee Arthroplasty: A Randomized Controlled Study

The functional outcome and longevity of total knee arthroplasty (TKA) is still a concern. Despite various developments in TKA designs, including fixed or mobile bearing, cruciate retaining or posterior stabilized, multi or single radius, it remains unclear which design is superior for achieving a physiological kinematic.

In normal healthy knees the medial and lateral tibial condyles are different: the medial is almost flat while the lateral is somewhat convex. Thus, the movement during flexion is asymmetric: during the flexion, the medial condyle is stable throughout the range of motion while the lateral condyle slides anteroposteriorly with respect to femur). Therefore, the native knee requires a specific degree of rollback of the lateral compartment coupled with a medial pivot, which leads to an external axial rotation of the femur. This rollback is thought to be even more pronounced with increasing knee flexion angles to enable deep flexion without excessive shear forces acting at the patella or overloading the extensor mechanism.

Read more

In addition, stability throughout flexion is a crucial element to normal knee function. Most TKA designs removal of the ACL, and the PCL in posterior-stabilized design, but the TKA do not fully restore the function of those ligaments.

Based on this philosophy, the medial pivot TKA was designed to provide better function, patient satisfaction and increased survival.

The objective of this study is to analyze whether the medial pivot design provides better outcome and prosthesis survival than conventional total knee arthroplasty.

Read the detailed description

Candidates for the study will be consecutive patients eligible for total knee arthroplasty (TKA) at our center. All patients meeting inclusion criteria will be recruited for enrollment into the study. Informed consent will be obtained from the patient prior to randomization.

At that time, each patient will be randomized into one of two groups by an independent staff using computer generated randomization and allocation concealment. The two patient groups will include:

  1. Study group: patients treated with a medial pivot TKA.
  2. Control group: patients treated with a conventional TKA. Patients will be preoperatively assessed and postoperatively at regular intervals (6mo, 12 mo, and then annually) by orthopaedic surgeons not involved in the surgeries or cares.
Being tested
total knee arthroplasty with medial pivot tibial insert or symmetrical insert
Keywords
knee osteoarthritis, Total knee arthroplasty, Medial pivot
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • total knee arthroplasty with medial pivot tibial insert or symmetrical insertDevice

    standard surgical implantation of total knee arthroplasty

Study groups in NCT04769544
Study groupRoleWhat they receive
Medial pivot groupActive comparatorDevice used: medial pivot total knee arthroplasty design
Receives: Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert
Conventional groupActive comparatorDevice used: conventional total knee arthroplasty design
Receives: Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Knee Society Score

    Functional KSS score (range 0-100) with higher scores as better outcome. A good result is defined as 70 points or greater

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2021
  2. Study start1 Jan 2022
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients will be treated surgically with a TKA. The two patient groups will include: 1) Study group treated a medial pivot TKA; 2) Control group treated with a conventional TKA. Patients will be followed at regular postoperative intervals by orthopaedic surgeons not involved in the surgeries or cares.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04769544
Sponsor's protocol ID
MedialPivotPTR2021
Status last verified
Apr 2022
First submitted
21 Feb 2021
Last updated
7 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing total knee arthroplasty with medial pivot tibial insert or symmetrical insert in people with Knee Osteoarthritis, run by Elda University Hospital at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alejandro Lizaur-Utrilla, MD, PhD (+34 966989019, lizaur1@telefonica.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Knee Society Score (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04769544 | AzTrials